Prevalence of drug-resistant tuberculosis in South Africa - Authors' reply

Affiliations

¹ National Institute for Communicable Diseases, Johannesburg, South Africa; Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa. Electronic address: naziri@nicd.ac.za.
² National Institute for Communicable Diseases, Johannesburg, South Africa.
³ National Department of Health, Tuberculosis Cluster, Pretoria, South Africa.
⁴ Medical Research Council, Respiratory and Meningeal Pathogens Research Unit, Johannesburg, South Africa; Department of Science, National Research Foundation, Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Comment

Nazir A Ismail et al. Lancet Infect Dis. 2018 Aug.

. 2018 Aug;18(8):836-837.

doi: 10.1016/S1473-3099(18)30422-5.

¹ National Institute for Communicable Diseases, Johannesburg, South Africa; Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa. Electronic address: naziri@nicd.ac.za.
² National Institute for Communicable Diseases, Johannesburg, South Africa.
³ National Department of Health, Tuberculosis Cluster, Pretoria, South Africa.
⁴ Medical Research Council, Respiratory and Meningeal Pathogens Research Unit, Johannesburg, South Africa; Department of Science, National Research Foundation, Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

No abstract available

Comment on

Prevalence of drug-resistant tuberculosis and imputed burden in South Africa: a national and sub-national cross-sectional survey.
Ismail NA, Mvusi L, Nanoo A, Dreyer A, Omar SV, Babatunde S, Molebatsi T, van der Walt M, Adelekan A, Deyde V, Ihekweazu C, Madhi SA. Ismail NA, et al. Lancet Infect Dis. 2018 Jul;18(7):779-787. doi: 10.1016/S1473-3099(18)30222-6. Epub 2018 Apr 21. Lancet Infect Dis. 2018. PMID: 29685458 Free PMC article.
Prevalence of drug-resistant tuberculosis in South Africa.
André E. André E. Lancet Infect Dis. 2018 Aug;18(8):835-836. doi: 10.1016/S1473-3099(18)30402-X. Lancet Infect Dis. 2018. PMID: 30064673 No abstract available.
Prevalence of drug-resistant tuberculosis in South Africa.
Mahla RS. Mahla RS. Lancet Infect Dis. 2018 Aug;18(8):836. doi: 10.1016/S1473-3099(18)30401-8. Lancet Infect Dis. 2018. PMID: 30064674 No abstract available.